in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cedarburg Hauser expands API capacity
8:12 AM MDT | September 19, 2013 | Deepti Ramesh
Cedarburg Hauser Pharmaceuticals (CHP; Grafton, WI) says it has upgraded its active pharmaceutical ingredient (API) manufacturing plant at Grafton. The upgraded facilities are expected to facilitate a 20–25% increase in API production, CHP says. These upgrades are a continuation of a long-term capital improvement initiative that results from an increased demand for the contract manufacturing of commercial APIs, CHP says. CHP is a contract development and manufacturing organization specializing in small molecule APIs and pharmaceutical intermediates...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee